·118·
ChinJGastroenterol,2011,Vol.16,No.2
pathwayandreducingbindingactivitiesofNF-kappaBandAP-1.Carcinogenesis,2008,29(1):147-156.9
EndoH,WatanabeT,SugiokaY,etal.ActivationoftwodistinctMAPKpathwaysgovernsconstitutiveexpressionofmatrixmetalloproteinase-1inhumanpancreaticcancercelllines.IntJOncol,2009,35(6):1237-1245.10
BaekMK,KimMH,JangHJ,etal.EGFstimulatesuPARexpressionandcellinvasivenessthroughERK,AP-1,andNF-kappaBsignalinginhumangastriccarcinomacells.OncolRep,2008,20(6):1569-1575.11
BaekMK,ParkJS,ParkJH,etal.LithocholicacidupregulatesuPARandcellinvasivenessviaMAPKandAP-1signalingincoloncancercells.CancerLett,2010,290(1):123-128.12
OchiK,HasuokaH,MizushimaT,etal.Acaseofsmallpancreaticcancerdiagnosedbyserialfollow-upstudiespromptlybyapositiveK-raspointmutationinpurepancreaticjuice.AmJGastroenterol,1998,93(8):1366-1368.13
RenYX,XuGM,LiZS,etal.DetectionofpointmutationinK-rasoncogeneatcodon12inpancreaticdiseases.WorldJGastroenterol,2004,10(6):881-884.14
ǐluI,YasaH,etal.Helicobacterpylori-KacarF,Meteog
inducedchangesinthegastricmucosaareassociatedwithmitogen-activatedproteinkinase(MAPK)activation.ApplImmunohistochemMolMorphol,2007,15(2):224-228.15
ShiC,FukushimaN,AbeT,etal.SensitiveandquantitativedetectionofKRAS2genemutationsinpancreatic
duct
juice
differentiates
patients
with
pancreaticcancerfromchronicpancreatitis,potentialforearlydetection.CancerBiolTher,2008,7(3):353-360.16
ZhouGX,HuangJF,LiZS,etal.DetectionofK-raspointmutationandtelomeraseactivityduringendoscopicretrogradecholangiopancreatographyindiagnosisofpancreaticcancer.WorldJGastroenterol,2004,10(9):1337-1340.17
ChenB,JinF,LuP,etal.Effectofmitogen-activatedproteinkinasesignaltransductionpathwayonmultidrug
2524232221201918
resistanceinducedbyvincristineingastriccancercelllineMGC803.WorldJGastroenterol,2004,10(6):795-799.
SunY,SinicropeFA.SelectiveinhibitorsofMEK1/ERK44/42andp38mitogen-activatedproteinkinasespotentiateapoptosisinductionbysulindacsulfideinhumancoloncarcinomacells.MolCancerTher,2005,4(1):51-59.
YokoiK,FidlerIJ.Hypoxiaincreasesresistanceofhumanpancreaticcancercellstoapoptosisinducedbygemcitabine.ClinCancerRes,2004,10(7):2299-2306.WaldnerMJ,NeurathMF.Themoleculartherapyofcolorectalcancer.MolAspectsMed,2010,31(2):171-178.
PerkinsG,LièvreA,RamacciC,etal.Additionalvalueof
EGFR
downstream
signaling
phosphoprotein
expressiontoKRASstatusforresponsetoanti-EGFRantibodiesincolorectalcancer.IntJCancer,2010,127(6):1321-1331.
BalmannoK,ChellSD,GillingsAS,etal.IntrinsicresistancetotheMEK1/2inhibitorAZD6244(ARRY-142886)isassociatedwithweakERK1/2signallingand/orstrongPI3Ksignallingincolorectalcancercelllines.IntJCancer,2009,125(10):2332-2341.
ZhangHH,WalkerF,KiflemariamS,etal.SelectiveinhibitionofproliferationincolorectalcarcinomacelllinesexpressingmutantAPCoractivatedB-Raf.IntJCancer,2009,125(2):297-307.
MaoJ,XuZ,FangY,etal.Hepatoma-derivedgrowthfactorinvolvedinthecarcinogenesisofgastricepithelialcellsthroughpromotionofcellproliferationbyErk1/2activation.CancerSci,2008,99(11):2120-2127.LaiTY,ChenLM,LinJY,etal.17beta-estradiolinhibitsprostaglandinE2-inducedCOX-2expressionsandcellmigrationbysuppressingAktandERK1/2signalingpathwaysinhumanLoVocoloncancercells.MolCellBiochem,2010,342(1-2):63-70.
(2010-09-07收稿)
热门文档